BRIEF-EMA Recommendations For June 2018

1 分钟阅读

June 29 (Reuters) - EU Medicines Agency:

* EMA RECOMMENDATIONS FOR JUNE 2018

* EMA RECOMMENDS APPROVAL OF NOVARTIS GENE-BASED CELL THERAPY KYMRIAH

* EMA RECOMMENDS APPROVAL OF BAXALTA' INNOVATIONS' DRUG FOR VON WILLEBRAND DISEASE VONICOG ALFA

* EU MEDICINES AGENCY RECOMMENDS APPROVAL OF ULTRAGENYX DRUG FOR TREATMENT OF SLY SYNDROME

* EU MEDICINES AGENCY RECOMMENDS APPROVAL OF GILEAD SCIENCES' CAR-T TREATMENT FOR ADVANCED NON-HODGKIN LYMPHOMA YESCARTA Source text ID: (bit.ly/2Ky9Rwj) Further company coverage:

我们的标准：汤森路透“信任原则”

0 : 0

narrow-browser-and-phone
medium-browser-and-portrait-tablet
landscape-tablet
medium-wide-browser
wide-browser-and-larger
medium-browser-and-landscape-tablet
medium-wide-browser-and-larger
above-phone
portrait-tablet-and-above
above-portrait-tablet
landscape-tablet-and-above
landscape-tablet-and-medium-wide-browser
portrait-tablet-and-below
landscape-tablet-and-below